Catalyst Pharmaceuticals, Inc.
USD31.44
-0.02 (-0.06%)
CEO
Richard John Daly
IPO Date
2006-11-08
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$31.43
Prev. Close
$31.46
Day Low
$31.43
Day High
$31.46
52W Low
$19.05
52W High
$32.56
Market Cap
$3.85B
Volume
0.25M
| 15.1 |
| 31 Dec 2023 | FY | 86.9% | 17.9% | 18.4% | 15.2% | 0.01 | 2.88 | 25.0 |
| 31 Dec 2022 | FY | 83.9% | 38.8% | 27.7% | 22.1% | 0.01 | 5.57 | 23.1 |
| 31 Dec 2021 | FY | 84.5% | 28.0% | 19.1% | 16.6% | 0.02 | 7.76 | 17.7 |
| 31 Dec 2020 | FY | 85.7% | 63.0% | 44.2% | 39.0% | 0.00 | 7.00 | 4.6 |
| 31 Dec 2019 | FY | 85.6% | 31.2% | 36.4% | 28.4% | 0.01 | 4.62 | 12.1 |
| 31 Dec 2018 | FY | -3883.8% | -6800.7% | -67.0% | -56.3% | 0.00 | 5.80 | -5.8 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -22.7% | -21.6% | 0.00 | 19.97 | -18.2 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | -46.0% | -43.3% | 0.00 | 19.79 | -4.8 |
| 13.5 |
| 30 Sept 2025 | Q3 | 82.9% | 35.6% | 5.7% | 5.0% | 0.00 | 6.62 | 11.4 |
| 30 Jun 2025 | Q2 | 79.6% | 35.6% | 6.1% | 5.4% | 0.00 | 6.71 | 12.7 |
| 31 Mar 2025 | Q1 | 87.3% | 40.1% | 7.1% | 6.2% | 0.00 | 6.14 | 13.0 |
| 31 Dec 2024 | Q4 | 84.7% | 39.4% | 7.7% | 6.6% | 0.00 | 5.17 | 11.2 |
| 30 Sept 2024 | Q3 | 85.0% | 34.1% | 6.6% | 5.7% | 0.00 | 5.11 | 13.5 |
| 30 Jun 2024 | Q2 | 87.4% | 33.2% | 6.7% | 5.8% | 0.01 | 5.14 | 11.4 |
| 31 Mar 2024 | Q1 | 87.3% | 23.6% | 4.1% | 3.6% | 0.01 | 5.09 | 19.7 |
| 31 Dec 2023 | Q4 | 85.7% | 31.5% | 9.0% | 7.4% | 0.01 | 2.88 | 12.9 |